We further investigated expression levels of CCND1, YAP, and TAZ mRNA by qRT-PCR in KIT-independent GIST cell lines (GIST48B and GIST226) after treatment with bortezomib for 24 h. This evidence concerns the gene CCND1 and gastrointestinal stromal tumor.